The mixed quarter, revenue beat but EPS miss and lowered EPS growth guidance, suggests limited near-term upside. Watch Q4 for sequential operational improvement and margin recovery; the 2.4x leverage target achieved provides some downside protection. The reaffirmed EBITDA guidance keeps the FY range intact, but the EPS downgrade signals tax headwinds that may cap earnings momentum into fiscal 2027.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 29 $72.84entry
- T+1 · 4mo ago −0.19%α −1.87% · $72.70
- T+5 · 3mo ago −1.57%α −7.09% · $71.70
- T+20 · 3mo ago +2.03%α −2.99% · $74.32
- T+60 · 26d ago +1.00%α −3.73% · $73.57
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Ashland reported Q3 2026 EPS of $0.91, missing consensus of $0.98 by 7.1%, while revenue of $497M beat the $486M estimate by 2.3%. Sales grew 7% YoY driven by volume gains across all segments, but adjusted EBITDA fell 4% YoY to $109M due to operational challenges and cost pressures. The company reaffirmed full-year sales and EBITDA guidance but lowered its adjusted EPS growth outlook to low-to-mid single digits, reflecting a higher tax rate, capping the upside from the revenue beat.
Key Financial Metrics
Key Facts
- EPS of $0.91 missed consensus of $0.98 (-7.1%)
- Revenue of $497M beat consensus of $486M (+2.3%) and grew 7% YoY
- Adjusted EBITDA of $109M declined 4% YoY; margin was 21.9%
- Life Sciences sales +11% YoY; Personal Care +5%; Specialty Additives +4%; Intermediates +12%
- Full-year sales guidance reaffirmed at $1,835-$1,870M; EBITDA guidance reaffirmed at $385-$400M
- Adjusted EPS growth outlook lowered to low-to-mid single digits from mid-to-high single digits
- Ongoing Free Cash Flow of $103M vs $108M prior year; net leverage at 2.4x
- Cash from operations $121M, up from $114M prior year
Financial Impact
EPS miss of $0.07 (-7.1%) vs consensus; revenue beat of $11M (+2.3%); adjusted EBITDA down $4M YoY
Risk Factors
- Lowered adjusted EPS growth guidance signals higher tax rate headwinds
- Adjusted EBITDA declined 4% YoY despite revenue growth, reflecting operational cost pressures
- Specialty Additives and Intermediates segments saw year-over-year EBITDA declines
- Macroeconomic uncertainty and elevated raw material/freight costs persist
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3334808 |
Track record
16 reports on ASH
1 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +11.29% at T+60 after the Jun 11, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $75.67 Now $75.57 −0.13% settles Nov 17
- Nov 11, 20265d ago Press Release Neutral 2/10 Entry $75.27 to $76.47 Now $75.57 +0.40% ▲ +1.59% +1.96% vs SPY
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bearish 5/10 Entry $76.44 to $76.28 Now $75.57 +1.14% ▲ +0.21% −4.20% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $74.68 to $74.19 Now $75.57 +1.19% ▼ −0.66% −0.18% vs SPY
- Oct 28, 202619d ago SC 13G/A Neutral 3/10 Entry $72.67 to $74.38 Now $75.57 +3.99% ▲ +2.35% +2.74% vs SPY
- Sep 25, 20267w ago 8-K Neutral 3/10 Entry $68.07 to $68.44 Now $75.57 +11.02% ▲ +0.54% +0.73% vs SPY
- Aug 15, 202613w ago Institutional Cluster Mixed 4/10 Entry $74.17 to $73.63 Now $75.57 +1.89% ▼ −0.73% −0.05% vs SPY
- Jul 28, 202615w ago Press Release Mixed 5/10 Viewing Entry $72.84 to $72.70 Now $75.57 +3.75% ▼ −0.19% −1.87% vs SPY
- Jul 14, 202617w ago Press Release Neutral 1/10 Entry $68.27 to $68.81 Now $75.57 +10.69% ▲ +0.79% +1.33% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers